4flow's Natalia Andreyeva breaks down the persistent planning failures driving AI adoption in pharma supply chains.
Natalia Andreyeva
Advertisement
Natalia Andreyeva is vice president, market strategy, at 4flow.
Articles by Natalia Andreyeva
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Q&A: Dr. Reddy's CEO on Generic Semaglutide and the GLP-1 Market Ahead
2
How Pharma 3PLs Are Rethinking Their Role in Drug Commercialization
3
Pharma Pulse: 340B Uncertainty, Drug Shortages, and Wegovy's Global Debut
4
FAQ: What Does the Medicare GLP-1 Bridge Mean for Pharma?
5